Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?
Russell
James W
JW
Department of Neurology, University of Michigan, MI 48109-0585, USA. jruss@umich.edu
D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003929:Diabetic Neuropathies / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D004311:Double-Blind Method; D000068736:Duloxetine Hydrochloride; D006801:Humans; D015337:Multicenter Studies as Topic; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010147:Pain Measurement / Q000187:drug effects; D011569:Psychiatric Status Rating Scales; D016032:Randomized Controlled Trials as Topic; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D000928:Antidepressive Agents; D013876:Thiophenes; D000068736:Duloxetine Hydrochloride